Search Results

0 results for 'Winston Strawn'

You can use to get even better search results
July 20, 1999 |

Cancer Claim for Drug Enjoined

Despite widespread reports last month that a drug approved to fight osteoporosis also decreases the risk of breast cancer among post-menopausal women, a federal judge has enjoined the drug's manufacturer from promoting the drug as protecting against cancer. U.S. District Judge John G. Koeltl, in Zeneca Inc. v. Eli Lilly and Co., last Thursday granted a preliminary injunction against drug maker Eli Lilly and Co.
3 minute read
Class of Energy Traders Certified in Case Against Amaranth
Publication Date: 2010-09-29
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Manhattan district judge Scheindlin: "As I (and others) have repeatedly stated, the fact that damages must be calculated on an individual basis" is not fatal to class certification.

SEC and BofA Will Defend $33 Million Settlement at Hearing Before Judge Rakoff on Monday
Publication Date: 2009-08-07
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

We weren't the only ones disgruntled at the relatively small fine the SEC levied against BofA to settle charges that the bank lied to investors about Merrill Lynch bonuses when BofA acquired Merrill last September. On Monday, Manhattan federal district court judge Jed Rakoff will grill lawyers from the agency and the bank on the details of the proposed settlement--including why it's so small and whether taxpayer money will be used.

February 24, 2006 |

No. 1 Task for Shearman Leader: Keeping the Firm in the Top Tier

With its illustrious history and posh name, Shearman & Sterling strikes many as the epitome of the patrician, white-shoe New York law firm. But the past few years have seen the 1,013-lawyer firm's image tarnished by associate layoffs, partner departures and signs of internal dissent, all capped by a profitability gap between Shearman and its erstwhile peers. Now the firm may be enjoying a fresh start, due partly to firm leader Rohan Weerasinghe and a 22 percent jump in profits per partner.
16 minute read
California Judge Dismisses MDL Against Amgen
Publication Date: 2008-12-23
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

We can't remember the last time a defendant won a motion to dismiss a class action in multidistrict litigation, so we took note of a decision last week by Los Angeles federal district court judge Philip Gutierrez in a case against the pharmaceutical giant Amgen and two dialysis service providers, DaVita and Fresenius Medical Care North America. The plaintiffs, seven health benefit plans, claimed in a class action that Amgen and the others conspired to promote off-label uses of two Amgen drugs, violating the federal RICO statute and California consumer fraud laws.

Chinese Company and Underwriters Lose Bid to Bounce Securities Class Action
Publication Date: 2012-08-28
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Counsel for Grant Thornton International at Willkie Farr managed to get their client off the hook in a securities class action involving Duoyuan Global Water Inc., but DGW and a group of underwriters represented by Shearman & Sterling are still on the hook.

April 19, 2006 |

Bailey, plaintiffs-appellants v. Fish & Neave, defendants-respondents

Panel Upholds Ruling That Law Firm Acted Properly In Vote to Defer Payments Due Departing Partners
13 minute read
Stars from Shearman & Sterling and Baker Botts Defect to Start Litigation Boutique
Publication Date: 2009-09-28
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

If there is a firm model built for the dawning post-recession era, it's probably a litigation boutique with low overhead and a flexible billing structure. That model has attracted two new converts: Steven Molo of Shearman & Sterling and Jeff Lamken of Baker Botts have announced that they're leaving their firms to start up MoloLamken.

EMI Adds Breach of Contract Suit to Record Label Litigation Against Grooveshark
Publication Date: 2012-01-06
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

The parent company of the EMI label claims that since it struck a licensing deal with Grooveshark in 2008, the digital music service hasn't made any royalty payments. EMI's suit follows a copyright infringement suit brought against Grooveshark by Universal, Sony, and Warner.

February 19, 2009 |

Newsbriefs

4 minute read

TRENDING STORIES

    Resources

    • A Buyer's Guide to Law Firm Software

      Brought to you by PracticePanther

      Download Now

    • A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster

      Brought to you by HaystackID

      Download Now

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now